Innovative Endotoxin Testing Technologies for Confident Decision-Making
What all successful laboratories have in common is the ability to combine efficient data management and cost optimization without compromising quality. For confident in-process and product release decisions, they need advanced and agile tools supporting streamlined workflows.
BioMérieux’s ENDONEXT™ technology, based on recombinant Horseshoe Crab Factor C (rFC), has 100% endotoxin specificity, lot-to-lot consistency for greater laboratory efficiency and competitive testing costs.
ENDONEXT™ does not require harvesting of horseshoe crab blood and offers long-lasting positive impacts on the planet by decreasing your laboratory environmental impact.
Learn more on how you can take a major step toward robust solutions that will support you in delivering on both your breakthrough products and sustainability goals.
ENDONEXT™ endotoxin detection assays are ushering in a new era of smarter, more sustainable pharmaceutical quality control.
The phenomenon of Low Endotoxin Recovery (LER) has gained renewed attention in the scientific community in recent years as the FDA now requires that all new Biological License Applications are able to successfully unmask when LER occurs. ENDOXPERTS™ is our solution for unmasking LER, which helps you meet regulatory requirements.